• Return to Headlines

Lowest Sales per Share in the Biotechnology Industry Detected in Shares of Vital Therapies (VTL, ZFGN, ACHN, AIMT, ATRA)

By James Quinn

Below are the three companies in the Biotechnology industry with the lowest sales per share. Sales per share is a valuable metric in comparing relative value for companies in the same industry.

Vital Therapies ranks lowest with a sales per share of $0.00. Zafgen Inc is next with a sales per share of $0.00. Achillion Pharma ranks third lowest with a sales per share of $0.00.

Aimmune Therapeu follows with a sales per share of $0.00, and Atara Biotherape rounds out the bottom five with a sales per share of $0.00.

SmarTrend is tracking the current trend status for Vital Therapies and will alert subscribers who have VTL in their portfolio or watchlist when shares have changed trend direction.

Keywords: lowest sales per share vital therapies zafgen inc achillion pharma aimmune therapeu atara biotherape

Ticker(s): VTL ZFGN ACHN AIMT ATRA